chrisvoncsefalvay/vaers-outcomes huggingface dataset:
got the first dose then got positive to Covid-19; got the first dose then got positive to Covid-19; This is a spontaneous report received from Pfizer sponsored program. A contactable consumer (patient's sister) reported that a male patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: unknown, expiry date unknown) via an unspecified route of administration on an unknown date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Reporter was calling on behalf of her brother (patient) and inquiring if you got the first dose and after you got positive to Covid-19 are you allowed to get the vaccine. Her brother got the first dose then got positive to Covid-19 on an unspecified date. The outcome of the events was unknown.  Information on the lot/batch number has been requested.
Subsequent to receiving first and second doses of varicella virus vaccine live a serum VZV antibody test revealed a lack of seroconversion.
flu-like symptoms; Vaccine exposure via breast milk; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu-like symptoms) and EXPOSURE VIA BREAST MILK (Vaccine exposure via breast milk) in a  patient of an unknown age and gender exposed to mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039A21A) , while the mother received the product for COVID-19 vaccination.    MEDICAL HISTORY (Parent): Concurrent medical conditions included Maternal exposure during breast feeding.    MEDICAL HISTORY (Patient): The patient's past medical history included No adverse event (Medical history not reported ).    On 09-Apr-2021, the mother received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 09-Apr-2021, the patient was diagnosed with EXPOSURE VIA BREAST MILK (Vaccine exposure via breast milk). On an unknown date, the patient was diagnosed with INFLUENZA LIKE ILLNESS (flu-like symptoms). On 09-Apr-2021, EXPOSURE VIA BREAST MILK (Vaccine exposure via breast milk) had resolved. At the time of the report, INFLUENZA LIKE ILLNESS (flu-like symptoms) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Transmammary) was unknown.       Concomitant product use was not provided by the reporter.  No treatment information was reported.   This case was linked to MOD-2021-079681 (Parent-Child Link).   See case MOD-2021-079681 for details regarding the Parent case.
Information has been received from a health professional concerning now a 4 year old female with asthma who on 06/24/1997 was vaccinated with varicella vaccine. On 11/24/2000 the pt experienced breakthrough varicella that lasted seven days. Subsequently, the pt recovered. Additional info has been requested.
Reported nausea and feeling light headed post vaccine. During medical monitoring x 30 mins symptoms slowly resolved. Released / ambulatory from facility with parent.
patient got the flu shot 20 years and got the flu; Initial information received on 14-Nov-2020 regarding an unsolicited valid non-serious case via consumer or non-health care professional.  This case involves patient of unknown demographics who got the flu shot 20 years and got the flu, while patient received vaccine INFLUENZA VACCINE [Flu shot].  Medical history, medical treatment, vaccination, concomitant medication and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer) [lot number and expiry date not reported] via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious patient got the flu shot 20 years and got the, (influenza) unknown latency following the administration of INFLUENZA VACCINE.  It was reported that, patient got the flu, 4 years no flu shot and no flu.  Details of laboratory data not reported.      It was not reported if the patient received any corrective treatment.  At the time of reporting, the event outcome reported as unknown for event.  There will be no information available on the batch number for this case.
Around 9pm on day of the shot I noticed injection site was sore and I was having some chills which progressively got worse as the next evening approached which then was accompanied with fatigue,  body aches, and low grade fever which all had pretty much subsided by Monday morning (10/18/21).  I did notice on Monday that the injection site was red and very warm as if there was fever present and still sore to the touch.  Although I have felt fine since the 18th, the injection site is still the same if not a tad bit of increase in redness and warm which is now 1:53pm 10/20.
This spontaneous report as received from an agency from a nurse refers to a patient of unknown age (age reported as between 6 years and 12 years old) and gender. The patient was enrolled in a program. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 28-JUL-2015, the patient was vaccinated with the improperly stored dose of VARIVAX (lot # K026386, expiration date 15-DEC-2016; dose and route of administration were not reported). It was reported that the vials of VARIVAX underwent temperature excursions as follows: 07-JUL-2015 8.9 degrees of Celsius for 1 hour and 28 minutes, on 28-JUL-2015 0.4 degrees of Celsius for 1 hour and 25 minutes. The nurse reported that the patient had not experienced any adverse events. Additional information has been requested.
Onset of adverse reactions started about 12 after injection. Symptoms were muscle pain in left are from injection site through neck, chills, cold sweats, nausea,  and extreme fatigue.  At some time during the night, I woke to use the restroom and fainted on the floor.  Symptoms lasted about 24 hours after onset.
After I received the vaccine, I had body aches and fever. Twice in the night I woke up with drenched pajamas. I started having symptoms on 10/12/2022 I had a sore throat and it felt like a sinus infection. I tested positive from a home test for COVID-19 on 10/15/2022. I had multiple tests for COVID-19, and it was finally confirmed on 10/19/2022. I got in touch with my doctor and was given a prescription for an inhaler.
Body rash, Tinnitus, Eye pain, headache, joint pain, muscle pain, shivering, abdominal pain and shivering.
Information regarding Prevnar was received from a consumer regarding a 6-month-old female patient who experienced injection site pain and injection site burning. At 6 months of age. the patient received a dose on an unspecified date. The patient also experienced injection site pain and injection site burning following Prevnar dose at 2 months of age (HQWYE622417AUG06). Indication for Prevnar was immunization. Product was administered on an unspecified date. Dose regimen was 1 dose 1 time per day (intramuscular). Concomitant medication were not reported. The patient experienced injection site pain (injection site pain) and injection site burning (injection site (irritation) following her 6 month Prevnar vaccination. See related case (s): HQWYE622417AUG06 (adverse event, non-expedited). No additional information was available at the time of this report.
CHILLS; BODY ACHE; DIZZINESS/LIGHTHEADEDNESS; INJECTION SITE PAIN; HEADACHE; FEVER; This spontaneous report received from a patient concerned a 31 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient had topical soaps allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported and batch number: 043A21A expiry: UNKNOWN) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, Laboratory data included: Body temperature (NR: not provided) 95.5 Unit not reported, 93.4 Unit not reported. On 08-APR-2021, the subject experienced dizziness/lightheadedness. On 08-APR-2021, the subject experienced injection site pain. On 08-APR-2021, the subject experienced headache. On 08-APR-2021, the subject experienced fever. On 08-APR-2021 17:30, the subject experienced body ache. On 08-APR-2021 17:30, the subject experienced chills. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body ache, chills, injection site pain, headache, and fever on 09-APR-2021, and had not recovered from dizziness/lightheadedness. This report was non-serious.
Pfizer-BioNTech COVID-19 Vaccine EUA  101.9 F fever, severe right arm pain, not being able to move any part of body without my right shoulder hurting.  Nausea, and mild fever for 24 hrs
The vial was initially stored in the refrigerator on 30-Mar-2023 and was administered on 04-May-2023; No adverse event; Dose administered after 30-day Use By Date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 30-Mar-2023 and was administered on 04-May-2023) and NO ADVERSE EVENT (No adverse event) in a 67-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7173B) for COVID-19 prophylaxis.     It was unknown whether patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine.     On 04-May-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 04-May-2023,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 30-Mar-2023 and was administered on 04-May-2023) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 30-Mar-2023 and was administered on 04-May-2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 30-Mar-2023 and was administered on 04-May-2023).    No concomitant medications were provided. It was administered within 5 days of the expiration of the beyond-use-date, which was 29-Apr-2023.  The vial size was 2.5 ml.  The vial was initially stored in the refrigerator on 30-Mar-2023. The vial did not undergo any temperature excursions. No treatment medication was provided.
Pt vaccinated with DT developed 2 min seizure - arms jerking eye movements - lst seizure in 4yrs.
PRIMARY EVENT 12/26/20, 48 yo well controlled asthma, got injection at 110p, sat in waiting area, then about 118p developed tickle in the throat, sensation like ?closing?. Denies stridor, wheezing, sob.  Doctor came by and assessed her, and then was given PO Benadryl 50mg. Symptoms didn?t worsen, and over time improved.  Went home around 230, throat was no longer tingling.   SECONDARY EVENT Reported a week of night sweats  myalagias, as well as rigors (12/26 - 1/2/21). Has had persistent axillary LAD, but more recently developed inquinal LAD as well. Non tender, just noticeable.  As of 1/6/21, no more sweats, no real fevers. But reports ongoing ?chills? and mild HA. She is still working and not incapacitated.
flu; Initial information received on 22-Nov-2020 regarding an unsolicited valid non-serious social media case from a consumer (patient).  This case involves a patient of unknown demographics, who got flu (influenza), when he/she received INFLUENZA VACCINE.  The patient's medical history, medical treatments, vaccinations, condition medications and family history were not provided.  On an unknown date, the patient received INFLUENZA VACCINE (batch number and expiry date unknown) via unknown route at unknown administration site for prophylactic vaccination.  On an unknown date, (latency unknown) after administration of INFLUENZA VACCINE, the patient got the flu and when he/she did, it was the worst flu ever (influenza). The patient haven't had one since.  No lab data was reported.  It was not reported if the patient received any corrective treatment.  At the time of report, the event outcome was unknown.  There will be no information available on the batch number for this case.
Redness, Swelling, Warmth.  About the 6 inches in length
Injection expired 7/29/23 (12 days ago) and was administered on 8/10/23.
pt recvd vax 4OCT93 & 24 hrs later began exp diarrhea which was cont for 24 hrs; No tx or MD visit as of 6OCT93
developed severe nose bleeds after receiving the first dose of vaccine; This is a spontaneous report from a contactable nurse received from Medical Information Team.  A 75-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 15Mar2021 (Batch/Lot number was not reported) as single dose for COVID-19 immunisation.  The patient medical history and concomitant medications were not reported.  The patient developed severe nose bleeds after receiving the first dose of vaccine on an unspecified date.  She was referred to an ENT and had to be cauterized.  The patient outcome of the event was unknown.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained.; Sender's Comments: Based on a temporal association, a causal relationship between the event nose bleeds and BNT162B2 cannot be completely excluded.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Information has been received from a woman in social services concerning a 17 month old male with no past medical history and no known allergies who was vaccinated with MMRII. There was no concomitant medication. Subsequently, the pt experienced fever. Unspecified medical attention was sought. Addition info has been requested.
whistling in her head/five people off the bat that has the same experience/ocean sound in her head; ocean sound in her head making her not sleep; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: TINNITUS (non-serious), outcome "unknown", described as "whistling in her head/five people off the bat that has the same experience/ocean sound in her head"; SLEEP DISORDER (non-serious), outcome "unknown", described as "ocean sound in her head making her not sleep ". Additional information: patient called about an ocean sound in her head making her not sleep and not put her head down. Reporter mentioned that there is still a whistling in her head while on the phone, she did not have it before. Reporter stated that it came from the Pfizer Vaccine and knows five people off the bat that has the same experience.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300125828 same reporter, product and event, different patient;US-PFIZER INC-202300125830 same reporter, product and event, different patient;US-PFIZER INC-202300125829 same reporter, product and event, different patient;
Slight pain at the injection site; Lowgrade headache; This is a spontaneous report from a contactable consumer (patient) who reported for himself and his wife. This is first of the two reports reported by the consumer (reporter case). A 70-year-old male patient received BNT162B2 (PFIZER COVID-19 VACCINE), via an unspecified route of administration, first dose on 07Jan2021 (Lot Number: EJ1685) and second dose on 07Feb2021 (Lot Number: EN53182) at single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. The consumer reported that no real side effects were encountered except slight pain at the injection site and low-grade headache that resolved within 24 hours. The outcome of the events was resolved. ; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021601624 same reporter/drug/AE, different patients
9Jan91 pt irritable around 700pm-low grade T than started high pitch crying (3 hrs)-T 102-APAP was given @ 830pm & 1100pm-finally went to sleep. Area where injection given, slightly red-MD was not notified
10 min after shots patient had a short 15 sec seizure and fainting episode. 30 min later looked pale and vomited x two. Sent to ER - did fine overnight.
Patient had a seizure on the morning of 10/22. The day after getting the flu shot. She had to be air lifted to hospital where she was in ICU for a few days. When she was taken off the vent and woke up she was paralyzed on her Right side and unable to speak. The MRI, EEG, EKG, Spinal tap and other test came back negative. We are currently on the therapy floor due to the paralysis. The doctors are puzzled as to why she still has all of these symptoms.
experienced severe headache; soreness at the site of injection; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (experienced severe headache) and VACCINATION SITE PAIN (soreness at the site of injection) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Mar-2021, the patient experienced HEADACHE (experienced severe headache) and VACCINATION SITE PAIN (soreness at the site of injection). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, HEADACHE (experienced severe headache) and VACCINATION SITE PAIN (soreness at the site of injection) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.
Participant received Janssen on 10/29/2021, at vaccine clinic partnered by Rehab Facility and Clinic, RN administered primary dose of Moderna at 0.5mL vs booster dose Moderna 0.25 mL on 1/28/2021.  RN informed participant of error after vaccine clinic, denied SE. Instructed to monitor for symptoms. Participant verbalized understanding of plan of care.
Information has been received from the mother of a 6 year old male who was vaccinated "several years ago" with Varivax. The child's mother reported that "recently " the child broke out with a mild case of chicken pox. The mother reported that the child "had some spots, but it was not all over his body". Unspecified medical attention was sought. At the time of this report, the outcome of the event was unknown. Additional information has been requested.
Broke out in mild chickenpox rash on trunk, scalp, inner thighs, on lesion in throat.
Husband (patient) just tested positive for COVID; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (Husband (patient) just tested positive for COVID) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Jan-2022, the patient experienced SARS-COV-2 TEST POSITIVE (Husband (patient) just tested positive for COVID). At the time of the report, SARS-COV-2 TEST POSITIVE (Husband (patient) just tested positive for COVID) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Jan-2022, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant drugs were not reported. Treatment medications were not provided.  It was reported that reporter is not sure if patient received Moderna vaccine.  Company Comment: This spontaneous case concerns a male patient, of unknown age, with no medical history reported, who experienced the unexpected, non-serious AESI of SARS-CoV-2 test positive after administration of an unspecified dose of the Moderna mRNA-1273 vaccine. The patient tested positive for COVID-19 on 07Jan2022. No further details were provided. The benefit-risk relationship of the Moderna mRNA-1273 vaccine is not affected by this report.   This case was linked to MOD-2022-445551, MOD-2022-445636 (Patient Link).; Sender's Comments: This spontaneous case concerns a male patient, of unknown age, with no medical history reported, who experienced the unexpected, non-serious AESI of SARS-CoV-2 test positive after administration of an unspecified dose of the Moderna mRNA-1273 vaccine. The patient tested positive for COVID-19 on 07Jan2022. No further details were provided. The benefit-risk relationship of the Moderna mRNA-1273 vaccine is not affected by this report.
This spontaneous case reported by a consumer, describes the occurrence of pain in extremity (arm pain), vaccination site rash (rash on her arm), pyrexia (fever) and chills in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On May 26, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On May 26, 2021, patient experienced pain in extremity (arm pain), vaccination site rash (rash on her arm), pyrexia (fever) and chills. At the time of the report, pain in extremity (arm pain), vaccination site rash (rash on her arm), pyrexia (fever) and chills outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. No concomitant medication or treatment information provided.
DVT blood clot in leg. Not able to seek care due to high deductible health insurance. Swelling, pain, discoloration, bruising in lower leg below soleus muscle and deep pain in calf. Using compression, ice, elevation, massage and aspirin regimen.
Client was administered the adult dosage of hepatitis A. Nurse called and spoke to mom, and advised her to watch for extra soreness in arm. Mom verbalized understanding.